4-Aminopyridine Does Not Enhance Flocculus Function in Tottering, a Mouse Model of Vestibulocerebellar Dysfunction and Ataxia

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Stahl, John S ^a,b   Thumser, Zachary C ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CEREBELLAR ATAXIA; CEREBELLUM DISEASE; CEREBELLUM FLOCCULUS; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EYE MOVEMENT; FEMALE; HABITUATION; MALE; MOUSE; NONHUMAN; OPTOKINETIC STIMULATION; PURKINJE CELL; TREATMENT RESPONSE; VESTIBULAR DISORDER; VESTIBULOCEREBELLAR DYSFUNCTION; VESTIBULOOCULAR REFLEX; VISION; VISUAL STIMULATION;

4-AMINOPYRIDINE; ANIMALS; ATAXIA; CEREBELLUM; EYE MOVEMENTS; MICE; MICE, INBRED C57BL; PURKINJE CELLS; REFLEX, VESTIBULO-OCULAR; ROTATION;

EID: 84874389145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057895     Document Type: Article

References (78)

1. Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, et al. (1999) Molecular diversity of K+ channels. Ann N Y Acad Sci 868: 233-285.
2. Rudy B, (1988) Diversity and ubiquity of K channels. Neuroscience 25: 729-749.
3. Sedehizadeh S, Keogh M, Maddison P, (2012) The use of aminopyridines in neurological disorders. Clin Neuropharmacol 35: 191-200.
4. Quartel A, Turbeville S, Lounsbury D, (2010) Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment. Curr Med Res Opin 26: 1363-1375.
5. Sanders DB, (1998) 3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS). Ann N Y Acad Sci 841: 811-816.
6. Strupp M, Brandt T, (2009) Current treatment of vestibular, ocular motor disorders and nystagmus. Ther Adv Neurol Disord 2: 223-239.
7. Kalla R, Glasauer S, Buttner U, Brandt T, Strupp M, (2007) 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain 130: 2441-2451.
8. Kalla R, Spiegel R, Claassen J, Bardins S, Hahn A, et al. (2011) Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus. J Neuroophthalmol 31: 320-325.
9. Sander T, Sprenger A, Marti S, Naumann T, Straumann D, et al. (2011) Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus. J Neurol 258: 618-622.
10. Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, et al. (2003) Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 61: 165-170.
11. Kalla R, Glasauer S, Schautzer F, Lehnen N, Buttner U, et al. (2004) 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain. Neurology 62: 1228-1229.
12. Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, et al. (2011) A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 77: 269-275.
13. Weisz CJ, Raike RS, Soria-Jasso LE, Hess EJ, (2005) Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering. J Neurosci 25: 4141-4145.
14. Alvina K, Khodakhah K, (2010) The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J Neurosci 30: 7258-7268.
15. Strupp M, Brandt T, (2006) Pharmacological advances in the treatment of neuro-otological and eye movement disorders. Curr Opin Neurol 19: 33-40.
16. Strupp M, Zwergal A, Brandt T, (2007) Episodic ataxia type 2. Neurotherapeutics 4: 267-273.
17. Hoebeek FE, Stahl JS, van Alphen AM, Schonewille M, Luo C, et al. (2005) Increased noise level of Purkinje cell activities can cancel impact of their modulation during sensorimotor control. Neuron 45: 953-965.
18. Walter JT, Alvina K, Womack MD, Chevez C, Khodakhah K, (2006) Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci 9: 389-397.
19. Etzion Y, Grossman Y, (1998) Potassium currents modulation of calcium spike firing in dendrites of cerebellar Purkinje cells. Exp Brain Res 122: 283-294.
20. Etzion Y, Grossman Y, (2001) Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 139: 419-425.
21. Kim CH, Oh SH, Lee JH, Chang SO, Kim J, et al. (2012) Lobule-specific membrane excitability of cerebellar Purkinje cells. J Physiol 590: 273-288.
22. Luthman J, Hoebeek FE, Maex R, Davey N, Adams R, et al. (2011) STD-dependent and independent encoding of input irregularity as spike rate in a computational model of a cerebellar nucleus neuron. Cerebellum 10: 667-682.
23. Glasauer S, Rossert C, Strupp M, (2011) The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus. Ann N Y Acad Sci 1233: 162-167.
24. Womack MD, Hoang C, Khodakhah K, (2009) Large conductance calcium-activated potassium channels affect both spontaneous firing and intracellular calcium concentration in cerebellar Purkinje neurons. Neuroscience 162: 989-1000.
25. Stahl JS (2012) New insights on the origin of downbeat nystagmus from channelopathy mutants and aminopyridines. In: Harris C, Gottlob I, Sanders J, editors. The Challenge of Nystagmus.Cardiff, UK: Nystagmus Network. pp. 59-74.
26. Bever CTJ, Young D, Anderson PA, Krumholz A, Conway K, et al. (1994) The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial. Neurology 44: 1054-1059.
27. Van Diemen HA, Polman CH, Koetsier JC, Van Loenen AC, Nauta JJ, et al. (1993) 4-Aminopyridine in patients with multiple sclerosis: dosage and serum level related to efficacy and safety. Clin Neuropharmacol 16: 195-204.
28. Vollmer T, Blight AR, Henney HR, 3rd (2009) Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study. Clin Ther 31: 2215-2223.
29. Ito M, Nisimaru N, Yamamoto M, (1977) Specific patterns of neuronal connexions involved in the control of the rabbit's vestibulo-ocular reflexes by the cerebellar flocculus. J Physiol 265: 833-854.
30. Stahl JS, Simpson JI, (1995) Dynamics of rabbit vestibular nucleus neurons and the influence of the flocculus. J Neurophysiol 73: 1396-1413.
31. Goossens HH, Hoebeek FE, Van Alphen AM, Van Der Steen J, Stahl JS, et al. (2004) Simple spike and complex spike activity of floccular Purkinje cells during the optokinetic reflex in mice lacking cerebellar long-term depression. Eur J Neurosci 19: 687-697.
32. Schonewille M, Luo C, Ruigrok TJ, Voogd J, Schmolesky MT, et al. (2006) Zonal organization of the mouse flocculus: physiology, input, and output. J Comp Neurol 497: 670-682.
33. van der Steen J, Simpson JI, Tan T, (1994) Functional and anatomical organization of three-dimensional eye movements in rabbit cerebellar flocculus. J Neurophysiol 72: 31-46.
34. Shin M, Moghadam SH, Sekirnjak C, Bagnall MW, Kolkman KE, et al. (2011) Multiple types of cerebellar target neurons and their circuitry in the vestibulo-ocular reflex. J Neurosci 31: 10776-10786.
35. van Neerven J, Pompeiano O, Collewijn H, (1991) Effects of GABAergic and noradrenergic injections into the cerebellar flocculus on vestibulo-ocular reflexes in the rabbit. Prog Brain Res 88: 485-497.
36. Hassul M, Daniels P, Kimm J, (1976) Effects of bilateral flocculectomy on the vestibulo-ocular reflex in the chinchilla. Brain Res 118: 339-343.
37. Nagao S, (1989) Behavior of floccular Purkinje cells correlated with adpatation of vestibulo-ocular reflex in pigmented rabbits. Exp Brain Res 77: 531-540.
38. Sato Y, Kawasaki T, (1990) Operational unit responsible for plane-specific control of eye movement by cerebellar flocculus in cat. J Neurophysiol 64: 551-564.
39. Stahl JS, (2004) Eye movements of the murine P/Q calcium channel mutant rocker, and the impact of aging. J Neurophysiol 91: 2066-2078.
40. Stahl JS, James RA, Oommen BS, Hoebeek FE, De Zeeuw CI, (2006) Eye movements of the murine p/q calcium channel mutant tottering, and the impact of aging. J Neurophysiol 95: 1588-1607.
41. Isaacs KR, Abbott LC, (1995) Cerebellar volume decreases in the tottering mouse are specific to the molecular layer. Brain Res Bull 36: 309-314.
42. Hourez R, Servais L, Orduz D, Gall D, Millard I, et al. (2011) Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J Neurosci 31: 11795-11807.
43. Isaacs KR, Abbott LC, (1992) Development of the paramedian lobule of the cerebellum in wild-type and tottering mice. Dev Neurosci 14: 386-393.
44. Leigh RJ, Zee DS (2006) The Neurology of Eye Movements; Gilman S, editor. New York: Oxford University Press. 762 p.
45. Zee DS, Yamazaki A, Butler PH, Gucer G, (1981) Effects of ablation of flocculus and paraflocculus on eye movements in primate. J Neurophysiol 46: 878-899.
46. Glasauer S, Stephan T, Kalla R, Marti S, Straumann D, (2009) Up-down asymmetry of cerebellar activation during vertical pursuit eye movements. Cerebellum 8: 385-388.
47. Stone LS, Lisberger SG, (1990) Visual responses of Purkinje cells in the cerebellar flocculus during smooth-pursuit eye movements in monkeys. I. Simple spikes. J Neurophysiol 63: 1241-1261.
48. Stahl JS, Oommen BS, (2008) Eye hyperdeviation in mouse cerebellar mutants is comparable to the gravity-dependent component of human downbeat nystagmus. Prog Brain Res 171: 503-508.
49. Halmagyi GM, Rudge P, Gresty MA, Sanders MD, (1983) Downbeating nystagmus: A review of 62 cases. Arch Neurol 40: 777-784.
50. Marti S, Palla A, Straumann D, (2002) Gravity dependence of ocular drift in patients with cerebellar downbeat nystagmus. Ann Neurol 52: 712-721.
51. Stahl JS, Thumser ZC, (2010) Effect of 4-aminopyridine on eye movements of Cacna1a mutant tottering challenges drug's presumed mechanism of action. Soc Neurosci Abstr 36: 848.841.
52. Oommen BS, Stahl JS, (2008) Eye orientation during static tilts and its relationship to spontaneous head pitch in the laboratory mouse. Brain Res 1193: 57-66.
53. Stahl JS, van Alphen AM, De Zeeuw CI, (2000) A comparison of video and magnetic search coil recordings of mouse eye movements. J Neurosci Methods 99: 101-110.
54. Stahl JS, (2002) Calcium channelopathy mutants and their role in ocular motor research. Ann NY Acad Sci 956: 64-74.
55. Stahl JS (2008) Characteristics and applications of mouse eye movements. In: Chalupa LM, Williams RW, editors. Eye, Retina, and Visual System of the Mouse. Cambridge: The MIT Press. pp. 872.
56. Capacio BR, Chang FC, Spriggs D, Byers CE, Matthews RL, et al. (1997) Pharmacokinetics and pharmacodynamics of 4-aminopyridine in awake guinea pigs. Drug Chem Toxicol 20: 151-172.
57. Sacco T, Tempia F, (2002) A-type potassium currents active at subthreshold potentials in mouse cerebellar Purkinje cells. J Physiol 543: 505-520.
58. Martina M, Yao GL, Bean BP, (2003) Properties and functional role of voltage-dependent potassium channels in dendrites of rat cerebellar Purkinje neurons. J Neurosci 23: 5698-5707.
59. Nicholson C, (1985) Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Res 333: 325-329.
60. Weber RB, Daroff RB, (1972) Corrective movements following refixation saccades: type and control system analysis. Vision Res 12: 467-475.
61. Langer T, Fuchs AF, Chubb MC, Scudder CA, Lisberger SG, (1985) Floccular efferents in the rhesus macaque as revealed by autoradiography and horseradish peroxidase. J Comp Neurol 235: 26-37.
62. Balaban CD, Schuerger RJ, Porter JD, (2000) Zonal organization of flocculo-vestibular connections in rats. Neuroscience 99: 669-682.
63. Godaux E, Vanderkelen B, (1984) Vestibulo-ocular reflex, optokinetic response and their interactions in the cerebellectomized cat. J Physiol 346: 155-170.
64. Curthoys IS, (2002) Generation of the quick phase of horizontal vestibular nystagmus. Exp Brain Res 143: 397-405.
65. Serafin M, Khateb A, de Waele C, Vidal PP, Muhlethaler M, (1990) Low threshold calcium spikes in medial vestibular nuclei neurones in vitro: a role in the generation of the vestibular nystagmus quick phase in vivo? Exp Brain Res 82: 187-190.
66. Furman JM, O'Leary DP, Wolfe JW, (1981) Changes in the horizontal vestibulo-ocular reflex of the rhesus monkey with behavioral and pharmacological alerting. Brain Res 206: 490-494.
67. Marti S, Straumann D, Buttner U, Glasauer S, (2008) A model-based theory on the origin of downbeat nystagmus. Exp Brain Res 188: 613-631.
68. Bense S, Best C, Buchholz HG, Wiener V, Schreckenberger M, et al. (2006) 18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus. Neuroreport 17: 599-603.
69. Kalla R, Deutschlander A, Hufner K, Stephan T, Jahn K, et al. (2006) Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurology 66: 281-283.
70. Glasauer S, Strupp M, Kalla R, Buttner U, Brandt T, (2005) Effect of 4-Aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus. Ann N Y Acad Sci 1039: 528-531.
71. Stahl JS, Thumser ZC, Oommen BS, (2012) The ataxic mouse as a model for studying downbeat nystagmus. J Vestib Res 22: 221-241.
72. Chen G, Popa LS, Wang X, Gao W, Barnes J, et al. (2009) Low-frequency oscillations in the cerebellar cortex of the tottering mouse. J Neurophysiol 101: 234-245.
73. Campbell DB, North JB, Hess EJ, (1999) Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background. Exp Neurol 160: 268-278.
74. Molgó J, Lemeignan M, Lechat P, (1985) Increase in evoked transmitter release from motor nerve terminals by some amino N-heterocyclic compounds. I. Comparative experimental activities and extracellular pH-dependence. Eur J Med Chem 20: 149-153.
75. Potter PJ, Hayes KC, Hsieh JT, Delaney GA, Segal JL, (1998) Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: three cases. Spinal Cord 36: 147-155.
76. Alvina K, Khodakhah K, (2010) KCa channels as therapeutic targets in episodic ataxia type-2. J Neurosci 30: 7249-7257.
77. Lemeignan M, Millart H, Lamiable D, Molgo J, P L, (1984) Evaluation of 4-aminopyridine and 3,4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized rats. Brain Res 304: 166-169.
78. Capacio BR, Byers CE, Matthews RL, Chang FC, (1996) A method for determining 4-aminopyridine in plasma: pharmacokinetics in anaesthetized guinea pigs after intravenous administration. Biomed Chromatogr 10: 111-116.